Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 3.2T | 3.0T | 2.9T | 2.5T |
Cost of revenue | 1.9T | 1.8T | 1.7T | 1.5T |
Gross profit | 1.3T | 1.2T | 1.1T | 1.0T |
Operating expense | ||||
Research & development | 163.4B | 157.1B | 154.1B | 150.5B |
Selling general and admin | 806.5B | 752.4B | 710.7B | 653.0B |
Other operating expenses | — | — | — | — |
Operating income | 330.2B | 276.7B | 273.1B | 229.7B |
Non operating interest income | ||||
Income | 13.4B | 12.2B | 7.7B | 4.6B |
Expense | 8.8B | 8.5B | 5.0B | 2.3B |
Other income expense | — | — | — | — |
Pretax income | 340.6B | 317.3B | 282.2B | 260.4B |
Tax provision | 77.6B | 78.1B | 65.2B | 57.1B |
Net income | 261.7B | 243.3B | 221.7B | 216.4B |
Basic EPS | — | — | 182.4 | 175.8 |
Diluted EPS | — | — | 182.1 | 175.4 |
Basic average shares | — | — | 1.2B | 1.2B |
Diluted average shares | — | — | 1.2B | 1.2B |
EBITDA | 516.0B | 451.1B | 430.1B | 391.3B |
Net income from continuing op. | 261.7B | 243.3B | 221.7B | 216.4B |
Minority interests | -728M | 212M | -2.3B | -5.3B |
Preferred stock dividends | 0 | 0 | 0 | 0 |